Hong Kong’s innovative deep-tech start-ups continue to thrive amid Covid-19
- Amid Covid-19 pandemic, Hong Kong Science and Technology Parks Corp holds first-ever virtual graduation ceremony for 108 incubation programme graduates
- Select group of graduates attend live event to share their stories and experiences with programmes
The global covid-19 pandemic has had a huge impact around the world and completely transformed societies and economies.
As the outbreak of the coronavirus disease continues, innovation and technology (I&T) companies are increasingly rising to the challenge to bring benefits to the community during these uncertain times.
Hong Kong Science and Technology Parks Corporation (HKSTP), which has been leading the I&T sector’s steady expansion in Hong Kong and around the region, continues to provide expertise and all-round support to help innovative start-ups get their brilliant ideas off the ground.
Langston Suen, CEO of Opharmic Technology, who founded his company in 2016 at Hong Kong Science Park, has invented a handheld device that, by applying a specific ultrasound frequency to a patient’s eyes, increases the permeability of the cell membrane without disturbing the eye tissues.
This means doctors and nurses can administer drugs in a non-invasive way – without the need for the painful alternative of intravitreal injections.
Suen came up with the idea during his PhD studies at the Hong Kong University of Science and Technology (HKUST).
